Maximum Fair Price Strategies for IPAY2027 Readiness

The shift from Year 1 to Year 2 introduces new challenges around pricing methodology, stakeholder alignment and downstream financial implications across the healthcare ecosystem.

Join this webinar to explore the impact of Year 2 MFP decisions, including comparisons with Year 1, stakeholder impact and broader effects on competitiveness, coverage and patient access.

The featured speakers will examine how the Centers for Medicare & Medicaid Services’ (CMS) approach has evolved, including shifts in price-setting logic and lessons learned from IPAY2026.

They will assess how different stakeholders may be affected by these changes, particularly in terms of who stands to gain or face new constraints under fixed pricing.

The webinar will also consider how the Trump administration might influence Medicare pricing policy and whether more aggressive approaches to MFP determinations could emerge.

Using real-world observations, the panel will highlight how current MFP decisions are influencing contracting strategies and shaping competitive responses across therapeutic areas.

Register for this webinar to learn how the MFP process is evolving and what it means for manufacturers, payers and policymakers navigating the Medicare landscape.

Keywords: Centers for Medicare and Medicaid Services, Commercialization/HEOR/Market Access, Drug Prices, Health Insurance, Healthcare Policy, Marketing, Medicare, Medicare Drug Price Negotiations, Payers, Regulatory